Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China flag China · Delayed Price · Currency is CNY
5.47
-0.04 (-0.73%)
Feb 21, 2025, 3:04 PM CST

Changzhou Qianhong Biopharma CO.,LTD Company Description

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China.

The company offers its products in the form of tablets, hard capsules, lyophilized powder and lyophilized powder injections, small-volume injections, and raw materials.

It provides enzymes, including pancreatic kininogenase series, asparaginase series, and compound digestive enzyme capsule II; and polysaccharides products, such as nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium.

The company also offers nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium injections.

In addition, it exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.

Changzhou Qianhong Biopharma CO.,LTD
Country China
Founded 1971
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,067
CEO Ke Wang

Contact Details

Address:
Life and Health Industrial Park
Changzhou, 213125
China
Phone 86 519 8515 6003
Website qhsh.com.cn

Stock Details

Ticker Symbol 002550
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100001070
SIC Code 2836

Key Executives

Name Position
Ke Wang GM and Non-Independent Director
Yi Yao Chief Financial Officer and Board Secretary
Xiang Zhou Deputy GM and Non-Independent Director
Lijun Wei Chief Engineer and Director
Chizhou Jiang Non-Independent Director and Deputy GM
Aiqun Xiao Audit Director
Juanwei Hua Deputy Director of Project Implementation Office and Non-Employee Supervisor